# Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease

> **NCT00043147** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Graft Versus Host Disease

## Interventions

- **DRUG:** beclomethasone dipropionate
- **DRUG:** methylprednisolone
- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT00043147
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00043147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00043147, "Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00043147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*